carbohydrate mimics: design, synthesis, and biological
TRANSCRIPT
Dipartimento di Chimica Organica e Industriale
Anna Bernardi Carbohydrate Mimics: Design, Synthesis, and Biological Activity
IASOC 2006Ischia, September 16 - 21, 2006
Organic Chemistry from Synthesis to the Interfaces of Life Sciences
Glycoconjugate and cell surfacerecognitionfrom Science 291, 2357 (2001)
www/sciencemag.org/Science Supplemental Material -- Carbohydrates Web Resources.htm
Electron micrograph of the glycocalixat the surface of a red blood cell
The glycocalix
Functions resulting from glycan-lectininteractions
Directing trafficking of glycoconjugates(intra- and extra-cellular)
Mediating and modulating cell adhesion(cell-cell, cell-matrix)
Mediating and modulating signalling(intra- and extra-cellular)
Sugar/protein interactions as targetDevelopment of probes, diagnostics and drugs
Sear, P.; Wong, C. H.; Angew. Chem. Int. Ed. 1999, 38, 2300
Cell surface carbohydrate-protein interactions play important roles in cell recognition processes.
Cell-cell interaction ( inflammation, fertilization)
Cell-virus interaction (e.g. flu virus)
Cell-molecules interaction (e.g. hormones, toxin)
Bacterial adhesion and biofilm formation (E.coli, H. pylori)
Carbohydrate - Protein interactions are involved in the early stages of many cell communication events, hence they are interesting targets for drug development
Oligosaccharide mimics could be made:metabolically stablemore bioavailableeasier to synthesizehigh affinity ligands ?
Oligosaccharides’drawbacks as drugs
metabolically unstable
low bioavailabilitydifficult to synthesizelow affinity ligands
Biotin – avidin complex
Oligosaccharide – MBP complex
small epitopes on complex scaffolds
REPLACE THE SCAFFOLDKEEP EPITOPE ORIENTATION
REPLACE THE SCAFFOLDKEEP EPITOPE ORIENTATION
HOO
OHO2C
O
OO O
HO
OHNHAc
OHOH
HO
O
OHOH
AcHN
sialyl Lewisx
HO
OMeOH
OH
HOO
OHO2C
OOH
O
OH
Ernst's mimic
HO
OMeOH
OH
Cy
IC50 (E) 80 µM800 µM
H. C. Kolb, B. Ernst Chem. Eur. J. 1997, 3, 1571 The sialyl Lewisx case
OO
OO
OH
XHO
O
HOO
OHO
HOW DO WE REPLACE AXIALLY SUBSTITUTED RESIDUES ?HOW DO WE REPLACE AXIALLY SUBSTITUTED RESIDUES ?
2 Manα1-X=OH 3,4-GalX= NHAc 3,4-GalNAc
DCCHD A Group of Conformationally Stable Cyclohexanediols
DCCHD A Group of Conformationally Stable Cyclohexanediols
OR
OR
CO 2RCO 2R
RO
RO
RO CO 2R
CO 2R
OR
CO 2RCO 2R
OR
ROCO 2R
CO 2RRO
RO
RO CO 2R
CO 2R
RO
RO CO 2R
CO 2R
CO 2R
CO 2R
ROOR
CO 2R
CO 2R
ROOR
CO 2R
CO 2R
RO
Rel. En.(kcal/mol)
0.0 + 4.1
0.0
0.0
+ 2.7
+ 3.7
Rel. En.(kcal/mol)
Rel. En.(kcal/mol)
MM3*
Bernardi, Arosio, Manzoni, Micheli, Pasquarello, Seneci J.Org.Chem. 66, 6209 (2001)
COOH
COOH
DCCHD: A Class of Pseudo-Monosaccharide Scaffolds
DCCHD: A Class of Pseudo-Monosaccharide Scaffolds
HO
HO CO2RCO2R
HOHO
CO2RCO2R
HO
OH
CO2RCO2R
(S,S)-Cyclohex-4-en-1,2-dicarboxylic acid
Bernardi, Arosio, Dellavecchia, Micheli Tetrahedron:Asymmetry 40, 3403 (1999)Bernardi, Arosio, Manzoni, Micheli, Pasquarello, Seneci J.Org.Chem. 66, 6209 (2001)
OsO4
1. MCPBA2. H2O
60% overall yieldNo intermediatepurificationBoth enantiomersavailable
H
H
O
O
O
CO2H
CO2HH
H
HOO
HOO
OHO The 1,2-disusbtituted α Mannose Case:
the oligomannose oligosaccharideThe 1,2-disusbtituted α Mannose Case:
the oligomannose oligosaccharide
Manα1-2Manα16Manα13 6 Manβ1- 4GlcNAcβ1 - 4GlcNAc3
Manα1-2Manα1-2Manα1
Manα1-2Manα1
Man9GlcNAc2, the least processedN-glycan from mature proteins
Man9GlcNAc2, the least processedN-glycan from mature proteins
OHOHO
OHOH
OOHO
HO
OR
OH
The Manα1-2Man fragment is recognizedby DC-SIGN, the dendritic cell receptor that
recognizes HIV-gp120 and other pathogens.
Polyvalent mannobiosides have potential as
antiviral compounds.
The Manα1-2Man fragment is recognizedby DC-SIGN, the dendritic cell receptor that
recognizes HIV-gp120 and other pathogens.
Polyvalent mannobiosides have potential as
antiviral compounds.
MC/EM
-240
-180
-120
-60
0
60
-60 0 60 120 180 240Phi
Psi
MC/SD, 10 ns
-240
-180
-120
-60
0
60
-60 0 60 120 180 240Phi
Psi
S
E
S E
OHOHO
OHOH
OOHO
HO
OMe
OH
α−(1,2)-Mannobiosideα−(1,2)-Mannobioside
AMBER* GB/SA waterMacroModel 5.5
AMBER* GB/SA waterMacroModel 5.5
X-Ray: both presentNMR: both must be present to satisfy NOE constraints
Phi: O5-C1-O1-C2’Psi: C1-O1-C2’-C1’
∆E S-E= 6 kJ/mol
Dwek et al Chem Rev. 2002, 102, 371-386
1’
3’1
1
HOO
HOO
OHO
1’
3’
55
Pseudo-1,2-MannobiosidePseudo-1,2-Mannobioside
MC/SD 10 ns
-240
-180
-120
-60
0
60
-60 0 60 120 180 240Phi
Psi
AMBER* , GB/SA waterAMBER* , GB/SA water
MeOOC
MeOOC
1. TMSOTf, -20°COAcO
AcO
OAc
OTCA
CO2MeCO2Me
HO
O
+ 2. MeONa/MeOH
2. Cu(OTf)2, AllOH
92%
1. MCPBA
OAcOHO
HO
OHOH
O
OR
RO2CRO2C
Manα1,2-Manα mimic
Eur. J. Org. Chem. 2004,5119
The NOE data closely parallel thosefound for the natural disaccharide and are in agreement with the two limitconformations predictedThe compound is more stable thanmannobioside to mannosidase-catalyzed hydrolysis
The NOE data closely parallel thosefound for the natural disaccharide and are in agreement with the two limitconformations predictedThe compound is more stable thanmannobioside to mannosidase-catalyzed hydrolysisES
HOO
HOO
OHO
Tetrameric, type II transmembrane protein (C-lectin), expressed by immature dendritic
cellsBinds to a broad spectrum of pathogens (including HIV, Ebola, Dengue, Leishmania
etc) mainly by targeting highly mannosylated glycoproteinsSome pathogens, including HIV, use DC-SIGN to infiltrate the immune systemDC-SIGN is currently regarded as a new target in infectious diseases
DC-SIGN Dendritic Cell-Specific ICAM-3 Grabbing Nonintegrin
The interaction is multivalentand Ca dependent
Mannose-based multivalentinhibitors of DC-SIGN havebeen reported (J. Rojo et al)
At mM concentration ps-1,2-mannobioside inhibitsDC-SIGN mediated viralentry in an Ebola model
HOO
HOO
OHO
MeOOC
MeOOC
1. Aniline, InBr3 CO2MeCO2Me
HN
OTBDMS
O2. TBDMSCl
ClCH2COClCO2Me
CO2Me
N
TBDMSO
Cl
O
CO2MeCO2Me
N
TBDMSO
O
Pd(OAc)2
PtBu2
N O
Ar
1. ArCHO, piperidineHO
CO2Me
CO2Me
Buchwald et al JACS 2003, xxxx
80%
40%
2. TBAF
Synthesis of potential kinase inhibitors
N O
Ar
OHm
Indolidinones are known kinase inhibitors
N-substitution with polyhydroxylated rings known to improve activity
Marco Re
Collaboration with Pierfausto Seneci - Unimi
HOO
HOO
OHO
O O OO
OO
-O2C
O
OO OR
HO
OHHO
HO
HO OH
OHOH
OHOH
HOAcHN
HOOH NHAc
OHOHGM1
III
N
IIIIV
R= Ceramide
GM1: Galβ1-3GalNAcβ1-4(Neu5Acα2-3)Galβ1-4Glcβ1-OR
GM2: GalNAcβ1-4(Neu5Acα2-3)Galβ1-4Glcβ1-OR
GM3 Neu5Acα2-3Galβ1-4Glcβ1-OR
GM4: Neu5Acα2-3Galβ1-OR
IV IN IIIII
The 3,4 disusbtituted Galactose Case:
Monosialo Gangliosides
The 3,4 disusbtituted Galactose Case:
Monosialo GangliosidesGangliosides are important constituents of biological membranes, particularly in the nervous system, where they participate in various recognition processes.Ganglioside GM1 is also the specific membrane receptor of Cholera Toxin (CT).
Gangliosides are important constituents of biological membranes, particularly in the nervous system, where they participate in various recognition processes.Ganglioside GM1 is also the specific membrane receptor of Cholera Toxin (CT).
OO
OO
OH
OH
O O OO
OO
HO2CO
OO O- ceramide
HO
OHHO
HO
HO OH
OHOH
OHOH
HO
HOOHAcNH
OHOH
AcHN
B5PENTAMER
ASUBUNIT
The cholera toxin
Mimicking the GM1-osMimicking the GM1-osO O O
OO
OHO2C
O
OO OH
HO
OHHO
HO
HO OH
OHOH
OHOH
HO
HOOH NHAc
OHOH
AcHN
O O OO
OHO2C
O
HO
OHHO
HO
HO OH
OHOH
HO
OH NHAc
AcHN
COORCOOR
GM1-os
ps-GM1
J. Am. Chem. Soc. 121, 2032 (1999)
GM1-os and ps-GM1 havethe same structure and the same affinity for CT
GM1-os and ps-GM1 havethe same structure and the same affinity for CT
O O O
HO2C
H
OHHO
HO
HO OH
OH AcHN O
O CO2RCO2R
R
ps-GM1
HO2C
HPh
HO2C
Me H
HO2C
HCy
KD (µM)
190
1010
45
Polyvalency improves the affinity to the nM range(Org. Biomol. Chem. 2004, 2113; J. Am. Chem. Soc. 2005,127, 3660 )
NMR studies have allowed rational design of the mimics(Org. Biomol. Chem. 2004,1, 785; Chem. Eur. J. 2002, 4597; Chem. Eur. J. 2004, 4395)
OO
OO
OH
OH
OSP
HN
HNSP
O
SCAFFOLD
psGM1
Linker
SP
OR
O O
RO
Spacer
R = Me, Et
O
OO O
H2N OO
O NH2
NH2H2N Linker
MeO2C
O
O
NH
O
NHO
O
O
NHBoc
NHBoc
O
O
NHBoc
NHBoc
Collaborazione conUniversità di Utrecht
SCAFFOLD O O OO
COOHCOOHCOOHHOOC
Collaborazione conUniversità di Parma
OO O
O
OBnO2C
HMe
OAcAcO
AcOOAc OAc
OAcNHAc
COOHCOOMepsGM1-(R)lat
190 µM
Org. Biomol. Chem. 2004, 2113 J. Am. Chem. Soc. 2005,127, 3660
POLYVALENT psGM1 LIGANDSPOLYVALENT psGM1 LIGANDSPOLYVALENT psGM1 LIGANDSOO
OO
OH
OH
NHO
H
OO
OOOH
OH
OH OH
OHOH
NHAcCOOMe
O
Me
NH
O O
NH
O3
O
O
Me
OO
OOOHOH
OHOH
OH OH
NHAcCOOMe
O
HNH
O NH
O
O O
NH
NH
NH
O
OO
O
O
O
HOOC
HOOC3 3
3
Divalent Calixarene: Fluorescence titrationsDivalentDivalent CalixareneCalixarene: : FluorescenceFluorescence titrationstitrations
In this assay, the divalentcalixarene appears more activethan the natural ligand o-GM1
In this assay, the divalentcalixarene appears more activethan the natural ligand o-GM1
IC50= 48 nMβ = 3950
0 .1 µ M C T
[L ] n M0 2 0 0 4 0 0 6 0 0 8 0 0 1 0 0 0 1 2 0 0 1 4 0 0
δI
0
2
4
6
8
1 0
o -G M 1d iv a le n t c a lix
J. Am. Chem. Soc. 2005,127, 3660
OO
OO
OH
OH
OOligosaccaride-O
OHNH
NHAc
OH
O NH
O
NH
O
peptide
β-N-Linked
peptide
In N-linked glycopeptides and glycoproteins the oligosaccharides are βlinked to the Asn side chain of a Asn-Xaa-Thr/Ser consensus sequenceKunz, H. et al Chem. Rev. 2000, 100, 4495-4537
OO
HOAcNH
OHα N-linked
HN
O HN
O
NH
O
peptide
peptide
Oligosaccaride
α-N-linked glycosylamides and glycopeptides are likely to be metabolically stable analoguesα-N-linked glycosylamides and glycopeptides are likely to be metabolically stable analogues
Their chemical properties and biological activity are virtuallyunexplored:
•one natural α-N-linked glycopeptide(nephritogenoside) isolated from natural sources (Shibata et al J.Biol.Chem.1998, 263, 12843)
• one synthetic α-N-linked chitobiosylpeptide: the configuration of the anomeric carbon controls the conformation of the peptide (Imperiali et alJ. Am. Chem. Soc. 2004, 127, 8421)
Their chemical properties and biological activity are virtuallyunexplored:
•one natural α-N-linked glycopeptide(nephritogenoside) isolated from natural sources (Shibata et al J.Biol.Chem.1998, 263, 12843)
• one synthetic α-N-linked chitobiosylpeptide: the configuration of the anomeric carbon controls the conformation of the peptide (Imperiali et alJ. Am. Chem. Soc. 2004, 127, 8421)
α-N-glycosylamides, a new class of glycoconjugatesα-N-glycosylamides, a new class of glycoconjugates
The stereoselective synthesis of α glycosylamides is not trivial
OHO
HOOH
OH
OH
NH3, NH4Cl0°C
OHO
HOOH
OH
NH2
OHO
HOOH
OH
NH2
H2ORNH2 + RI
3P O
+ RI3P ORNHCORII
1) RIICOX
2) H2OR N PRI
3
R''CO X
R = PyranoseR = Pyranose
N3R R N PRI3+ RI
3P
Staudinger reduction/acylation can be used to avoid amineanomerization
iminofosforane
AcOAcO
N3
AcO
OAcO
AcOAcO
NHAcOAc
OAcO
AcOAcO
NHCOCF3
AcO
OAcO
a. PMe3b. Ac2O
b. (CF3CO)2Oa. PMe3
Resa = 80%
Resa = 51%
Kovács, L.; Ösz, E.; Domokos, V.; Holzer, W.; Györgydeák, Z. Tetrahedron 2001, 57, 4609-4621.
100% β
100% α
However, the iminofosforane is also prone to isomerization
O
NRO
PR'3
ONRO PR'3
kacRIICOX
ON
RO PR'3
COR''
x
keq keq
Selectivity dependson the kac/keq ratio
Selectivity dependson the kac/keq ratio
O
NRO
PR'3
O
N3
ROPR'3
RIICOX
O
N
RO
PR'3R''OC
x
kac
O
N3OAc
AcOAcO
OAcO
NOAcO
AcO
OAc
Me
PPh3
ON
OAcAcO
AcO
OAc
O
NAcO
AcO
OAc
N2
O
Me
OPPh3
PPh3
ON
OAcAcO
AcO
OAc
PPh3
O=PPh3
RCOSPy
Cu2+
O
NHCORAcOAcO
AcO
OAc
Damkaci, F.; DeShong, P. J. Am. Chem. Soc. 2003, 125, 4408
DeShong Isoxazoline Method
PPh2O
O
ROBnO
BnO
N3BnO
OBn
+
OBnO
BnOHN
BnO
OBn
O
R
α
OHO
HOHN
OH
OH
O
R
Bianchi A., Bernardi A. Tetrahedron Letters 2004, 2231; J. Org. Chem. 2006, 4565
The Staudinger ligation: a general method for the synthesis of α-glycosylamides
The Staudinger ligation: a general method for the synthesis of α-glycosylamides
OBnOBnO
OBn
BnON
Ph2PR
OOO
R
O
OBnOBnO
OBn
BnON
PPh2
The intramolecular acyltransfer competes more efficiently with the anomerization process
The intramolecular acyltransfer competes more efficiently with the anomerization process
H2O
O
N3BnO
BnOBnO
OBn
O
NHCOCH3BnO
BnOBnO
OBn
1.2 eq
y = 77%
O
N3BnO
BnO
BnO OBn
O
NHCOCH3BnO
BnO
BnO OBn
1.2 eqy = 73%
Staudinger ligation: acetylation of α-glycosyl azidesStaudinger ligation: acetylation of α-glycosyl azides
α only
OAc
PPh2
OAc
PPh2
Bianchi, A.; Bernardi, A. Tetrahedron Lett. 2004 45, 10, 2231-2234
β only
O
N3BnO
BnOBnO
OBn
2) PFP-OAc
ONHCOCH3
BnO
BnOBnO
OBn1) PMe3 y = 77%
α only
>97:35685:1565-CH=C(CH3)2
93:765---(CH2)3COOMe
α/β ratioYield (%)α/β ratioYield (%)R =
--100:077-CH3
>97:37684:1640-CH(CH3)2
95:58183:1770-CH2CH(CH3)2
93:78384:1660-(CH2)3CH3
Method B (DMF)Method A (CHCl3, hν)
O
N3BnO
BnOBnO
OBn
PPh2
OCOR
O
NHCORBnO
BnOBnO
OBn
+
B nO O
NB nO
B nO
O B n
NN
PPh 2R O C O
B nO O
NB nO
BnO
O B n
NN
PPh 2R O C O
P Ph 2
O R
O
BnO O
NB nO
B nO
O B n
Ph 2P
O
R O C
BnO O
N 3B nO
B nO
O Bn
PP h2O H
OH 2O
B nO O
NB nO
B nO
O B n
NN
Ph 2P
R O C O
N 2
BnOO
N H C O RBnO
B nO
O Bn
B nOO
NB nO
B nO
O B n
P h2P
O
C O R
+
EZ
triazad iene
im inophosphorane (aza-y lide)
A. Bianchi, A. Russo, A. Bernardi Tetrahedron: Asymmetry 2005, 16, 381-386
Mechanism of the Staudinger ligation of glycosyl azides
solvent α/β ratio Yield (%)Toluene 86:14 75*1:3 DMA:Tol 75:25 66
+
OPPh2
O NHCbz
O
OMe O
NHBnOBnO
BnO
OBn
O
COOMe
NHCbz
O
N3BnO
BnOBnO
OBn
O
N3BnO
BnO
BnO OBnPPh2
O
O Me
MeO
HNBnOBnO
BnO OBn
O Me
Me
α : β 98 : 2
70%
H2 (4 atm), Pd-C
DMA / AcOH / H2O85 : 10 : 5
O
NHBnO
BnOBnO
OBn
O
COOMe
NHCbz
O
NHHO
HOHO
OH
O
COOMe
NH2
DeprotectionDeprotection
O
N3HO
HOHO
OH
PPh2
OCOR
O
NHCORHO
HOHO
OH
+ DMA, 2% DMPU
NHCOR
H
HH OH
OH HO
HHO
HO+
..or no protection..or no protection
98:256 -(CH2)3COOMe
98:220
> 98:250-(CH2)3CH3
α/β ratioYield (%)R =
> 98:240
O
N3HO
HOHO
OH
PPh2
OCOR
O
NHCORHO
HOHO
OH
+ DMA/DMPU
Filippo Nisic
-H2C OMe
O
NHCbz
-H 2 CO M e
O
N H C b z
O
NHCOCH3OH
H2
HO
H3
H4
HO
H5
H1
OH
O
NHCOCH3OH
H2
HO
H3
OH
H4
H5
H1
OH
s
s
s s
ss
s
m
mm
w
w w
O
NHCOCH3
H3C
H3
OHOH
H5
H1
OH
The α-glycosylamides examined so far conserve the usual chairconformation of the pyranose ring
The α-glycosylamides examined so far conserve the usual chairconformation of the pyranose ring
4C11C4
Good mimicry of the sugar !
Università di Milano
Daniela ArosioSilvia MariAldo BianchiGiancarlo TerraneoDonatella InvernizziČrtomir PodlipnikGilles MarcouHelena PosteriPierangelo MereghettiAndrea RussoFilippo NisicMarco ReSara Sattin
Donatella PotenzaLaura BelvisiPierfausto Seneci
MadridJesus Jiménez-BarberoJavier Caňada
MIURCNR – ISTMCISIEuropean Network Glycidic ScaffoldsGSK - Verona
€
SevillaJavier RojoJosé ReinaPedro Nieto
CSIC
IBS – GrenobleFranck FieschiGeorges Tabarani
Università di ParmaRocco UngaroAlessandro CasnatiFrancesco SansoneMarco Fontanella